Agilent Technologies Inc（A）财务数据AAgilent Technologies Inc

Agilent Technologies Inc (A) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Non-instrumentation and other, accounting for 63.4% of total sales, equivalent to $1.14B. Another important revenue stream is Instrumentation. Understanding this composition is critical for investors evaluating how A navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Agilent Technologies Inc maintains a gross margin of 55.48%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 23.64%, while the net margin is 19.28%. These profitability ratios, combined with a Return on Equity (ROE) of 20.97%, provide a clear picture of how effectively A converts its operational activities into shareholder value.

In the context of the broader market, A competes directly with industry leaders such as IDXX and WAT. With a market capitalization of $41.95B, it holds a significant position in the sector. When comparing efficiency, A's gross margin of 55.48% stands against IDXX's 64.04% and WAT's 29.79%. Such benchmarking helps identify whether Agilent Technologies Inc is trading at a premium or discount relative to its financial performance.

Agilent reported a net income of $362 million for Q3 FY2026, up from $336 million a year ago, and a gross margin of 55.48%, reflecting strong profitability. The company has also shown consistent revenue growth, with Q3 revenue reaching $1.88 billion, exceeding analyst expectations.